CBD for athletes: 4 recovery trials and anti-doping rules
Athletes have been allowed CBD since 1 January 2018. Every other cannabinoid is still banned in competition, including the THC, CBG and CBDV found in full- and broad-spectrum products. Four controlled trials on recovery, published between 2021 and 2026 with CBD taken by mouth or as a cream, measured no clear drop in muscle soreness and no faster return of strength. For a tested athlete, the risk stays low only with a CBD isolate whose analysis detects no other cannabinoid.
Key takeaways
- In competition, the 2026 list of the World Anti-Doping Agency (WADA) bans every cannabinoid "except cannabidiol".
- A 2026 study found CBG, a prohibited cannabinoid, in 74% of urine samples after exercise, from a broad-spectrum CBD with no detectable THC.
- Four controlled trials of 13 to 28 participants found no clear effect of CBD on soreness or strength.
- A CBD product may not claim any effect on recovery, performance or inflammation.
- The documented levers of recovery are still sleep, protein intake and training planning.
Why so many athletes are interested
Contact sports in particular show real use. In 2020, a survey of 517 professional rugby players from 25 teams found that 26% had used CBD or still used it, and 41% of players aged 28 and over. They cited recovery and pain (80%) and sleep (78%). Only 16% had consulted a nutritionist; most had found their information online or through a teammate.
The authors concluded that players needed information on anti-doping risks. This article starts from the same observation: the enthusiasm arrived before the evidence.
What controlled trials measured
Since 2021, several teams have compared CBD with placebo after exercise designed to cause micro-damage to muscle, the damage behind soreness on the following days. Their results point the same way.
| Study | Participants | Product and dose | Main result |
|---|---|---|---|
| Cochrane-Snyman et al., 2021 | 13 untrained men | Oil, 150 mg three times | No effect on soreness, strength or swelling |
| Isenmann et al., 2024 | 17 trained athletes | Oil or soluble form, 60 mg after each session, 6 days | No clear effect on performance or inflammation |
| Pastina et al., 2025 | 28 adults | Cream, about 100 mg on the thighs | No effect on pain, jump or strength |
| Mendes et al., 2026 | 15 active students | Gel, 2 g on the thighs over 72 h | No effect on soreness or muscle marker |
Two results need a closer look. In Isenmann's trial, the oil lowered myoglobin, a marker of muscle damage, in the less elite group of athletes, without any effect on performance. Mendes recorded a slight advantage in isometric strength, with no change in soreness. Both teams conclude that there is no clear effect.
A 2024 systematic review retained seven studies out of 901 publications and calls the data on strength and recovery "limited". In 2025, the Permanent Senate Commission on Food Safety of the German Research Foundation (SKLM) examined the CBD doses found in food products. It found no evidence that would support a health claim on physical performance, sleep or pain. It also recorded a rise in liver enzymes in healthy volunteers from 4.3 mg/kg a day taken for three to four weeks.
In France, this has a practical consequence: a seller who promises faster recovery, less soreness or an anti-inflammatory effect is making an unauthorised health claim. Our article on what clinical studies really say looks at the question beyond sport.
Anti-doping: CBD allowed, the rest of the spectrum not
France publishes the prohibited list every year in its Official Journal; for 2026, it is decree no. 2025-1226 of 15 December 2025. Its section S8 bans all natural and synthetic cannabinoids in competition, with one exception: "cannabidiol". The change dates from 2018. The US Anti-Doping Agency summed it up as CBD no longer prohibited under the S8 category, and added that CBD extracted from the plant can contain THC.
THC is only part of the trap. CBG and CBDV, two cannabinoids found in "broad-spectrum" products, are prohibited as well. A study published in 2026 in Medicine & Science in Sports & Exercise measured the problem. Thirty-six volunteers took a broad-spectrum CBD at 150 mg a day, or a placebo, for ten weeks. No THC was detected. CBG, though, appeared in 42% of urine samples before a 90-minute exercise session and in 74% after; CBDV in 68%, then 84%. Exercise pushed the concentrations up.
France's anti-doping agency, AFLD, takes the same position. Some CBD oils or extracts "could contain other cannabinoids" that are banned, and what counts is the presence of the substance in the body, whatever the time of intake. Our article on CBD and the 2026 WADA list covers the urinary THC threshold, the decision limit and the sanctions.
Choosing a product if you are tested
Start with one question: do you take part in competitions organised or authorised by a sports federation? If you do, the format matters more than the brand.
| Format | What it contains | Anti-doping risk |
|---|---|---|
| Isolate | Purified CBD, in principle with no other cannabinoid | Lowest, if the analysis confirms it |
| Broad spectrum | CBD and other cannabinoids, THC removed | Real: CBG and CBDV are prohibited |
| Full spectrum | The plant's whole profile, THC included under 0.3% | Highest |
| Flower, resin | THC and THCA always present | High, avoid |
The label alone does not make an isolate safe. The certificate of analysis must cover the batch you bought and show "not detected" for Δ⁹-THC, as well as for CBG, CBDV and CBN where the lab looked for them. Our article on 99% isolate explains what that figure guarantees and where its guarantee stops, and the guide to reading a certificate of analysis takes each line in turn. For a comparison of formats, see full spectrum or isolate.
Two other rules apply to everyone, whether or not they compete. Semi-synthetic cannabinoids are controlled drugs in France: HHC since June 2023, H4CBD and THCP since June 2024, as explained in our article on the H4CBD ban. Since May 2026, CBD oils, capsules and supplements meant to be swallowed have also been withdrawn from sale under the Novel Food regulation; our overview of CBD regulation in 2026 has the details. What remains are cosmetics, balms and massage oils, which go on the skin and fall under a different framework.
People who compete in no official event, at the gym or in recreational CrossFit, are not subject to these tests. All three formats are then legal under the 0.3% THC threshold. The trials above still apply to them: nothing shows that CBD speeds up their recovery.
What remains documented for recovery
The levers with a measured effect are familiar ones. Sleep comes first: the American Academy of Sleep Medicine and the Sleep Research Society recommend at least seven hours a night for adults. What research says about CBD in this area, and what it leaves open, is in our article on CBD and sleep.
Nutrition comes next. The International Society of Sports Nutrition puts most athletes' needs at 1.4 to 2.0 g of protein per kilo per day, in servings of 20 to 40 g every 3 to 4 hours. Load planning, with lighter weeks, and hydration complete the list.
If you want a CBD ritual after exercise, the format that fits French rules is a cosmetic applied during a massage. Many routines already include massage; in the two cream and gel trials, the added CBD had no measurable effect. Our guide to assessing a CBD cream or balm explains what to read on the label. For persistent pain, see a sports doctor or a physiotherapist.
Frequently asked questions
Yes. WADA has allowed cannabidiol since 2018, in competition too. Every other cannabinoid is still prohibited, THC, CBG and CBDV included. The risk of a positive test stays low only with an isolate whose batch analysis detects no other cannabinoid.
No. In the 2026 study described above, a broad spectrum with no detectable THC left CBG in 74% of urine samples after exercise, and CBDV in 84%. Both are prohibited in competition.
Controlled trials published between 2021 and 2026 found no clear effect on soreness, strength or performance, and no claim of this kind is authorised for a CBD product.
Since May 2026, CBD oils meant to be swallowed can no longer be sold as food in France. For a recreational athlete, nothing suggests that they speed up recovery. A competitor also faces the anti-doping risk unless the product is a verified isolate.
None of the studies cited here measured that risk for a balm, and AFLD says it cannot guarantee the composition of any cosmetic. A careful competitor picks a balm made with an isolate and checks the batch analysis.
Written by the Phytogrammes team
Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.
Article published on . CBD is not a medicine.